117 related articles for article (PubMed ID: 16983334)
21. Inhibition of S-adenosylmethionine decarboxylase by inhibitor SAM486A connects polyamine metabolism with p53-Mdm2-Akt/protein kinase B regulation and apoptosis in neuroblastoma.
Koomoa DL; Borsics T; Feith DJ; Coleman CC; Wallick CJ; Gamper I; Pegg AE; Bachmann AS
Mol Cancer Ther; 2009 Jul; 8(7):2067-75. PubMed ID: 19584241
[TBL] [Abstract][Full Text] [Related]
22. The long non-coding RNA GAS5 differentially regulates cell cycle arrest and apoptosis through activation of BRCA1 and p53 in human neuroblastoma.
Mazar J; Rosado A; Shelley J; Marchica J; Westmoreland TJ
Oncotarget; 2017 Jan; 8(4):6589-6607. PubMed ID: 28035057
[TBL] [Abstract][Full Text] [Related]
23. PI3K inhibitors prime neuroblastoma cells for chemotherapy by shifting the balance towards pro-apoptotic Bcl-2 proteins and enhanced mitochondrial apoptosis.
Bender A; Opel D; Naumann I; Kappler R; Friedman L; von Schweinitz D; Debatin KM; Fulda S
Oncogene; 2011 Jan; 30(4):494-503. PubMed ID: 20856197
[TBL] [Abstract][Full Text] [Related]
24. Subcellular Distribution of p53 by the p53-Responsive lncRNA
Mitra S; Muralidharan SV; Di Marco M; Juvvuna PK; Kosalai ST; Reischl S; Jachimowicz D; Subhash S; Raimondi I; Kurian L; Huarte M; Kogner P; Fischer M; Johnsen JI; Mondal T; Kanduri C
Cancer Res; 2021 Mar; 81(6):1457-1471. PubMed ID: 33372039
[TBL] [Abstract][Full Text] [Related]
25. Proteasome inhibitors suppress the protein expression of mutant p53.
Halasi M; Pandit B; Gartel AL
Cell Cycle; 2014; 13(20):3202-6. PubMed ID: 25485499
[TBL] [Abstract][Full Text] [Related]
26. A small synthetic peptide, which inhibits the p53-hdm2 interaction, stimulates the p53 pathway in tumour cell lines.
Chène P; Fuchs J; Bohn J; García-Echeverría C; Furet P; Fabbro D
J Mol Biol; 2000 May; 299(1):245-53. PubMed ID: 10860736
[TBL] [Abstract][Full Text] [Related]
27. Levels of HdmX expression dictate the sensitivity of normal and transformed cells to Nutlin-3.
Patton JT; Mayo LD; Singhi AD; Gudkov AV; Stark GR; Jackson MW
Cancer Res; 2006 Mar; 66(6):3169-76. PubMed ID: 16540668
[TBL] [Abstract][Full Text] [Related]
28. The interaction between FAK, MYCN, p53 and Mdm2 in neuroblastoma.
Waters AM; Beierle EA
Anticancer Agents Med Chem; 2014 Jan; 14(1):46-51. PubMed ID: 24041229
[TBL] [Abstract][Full Text] [Related]
29. Cyclin-dependent kinase inhibitors sensitize tumor cells to nutlin-induced apoptosis: a potent drug combination.
Cheok CF; Dey A; Lane DP
Mol Cancer Res; 2007 Nov; 5(11):1133-45. PubMed ID: 18025259
[TBL] [Abstract][Full Text] [Related]
30. Mouse double minute antagonist Nutlin-3a enhances chemotherapy-induced apoptosis in cancer cells with mutant p53 by activating E2F1.
Ambrosini G; Sambol EB; Carvajal D; Vassilev LT; Singer S; Schwartz GK
Oncogene; 2007 May; 26(24):3473-81. PubMed ID: 17146434
[TBL] [Abstract][Full Text] [Related]
31. Stabilization and activation of p53 induced by Cdk5 contributes to neuronal cell death.
Lee JH; Kim HS; Lee SJ; Kim KT
J Cell Sci; 2007 Jul; 120(Pt 13):2259-71. PubMed ID: 17591690
[TBL] [Abstract][Full Text] [Related]
32. Intrinsic ubiquitination activity of PCAF controls the stability of the oncoprotein Hdm2.
Linares LK; Kiernan R; Triboulet R; Chable-Bessia C; Latreille D; Cuvier O; Lacroix M; Le Cam L; Coux O; Benkirane M
Nat Cell Biol; 2007 Mar; 9(3):331-8. PubMed ID: 17293853
[TBL] [Abstract][Full Text] [Related]
33. Characterization and optimization of a novel protein-protein interaction biosensor high-content screening assay to identify disruptors of the interactions between p53 and hDM2.
Dudgeon DD; Shinde SN; Shun TY; Lazo JS; Strock CJ; Giuliano KA; Taylor DL; Johnston PA; Johnston PA
Assay Drug Dev Technol; 2010 Aug; 8(4):437-58. PubMed ID: 20662736
[TBL] [Abstract][Full Text] [Related]
34. HDM2 regulation by AURKA promotes cell survival in gastric cancer.
Sehdev V; Katsha A; Arras J; Peng D; Soutto M; Ecsedy J; Zaika A; Belkhiri A; El-Rifai W
Clin Cancer Res; 2014 Jan; 20(1):76-86. PubMed ID: 24240108
[TBL] [Abstract][Full Text] [Related]
35. Suppression of hypoxia-inducible factor 2alpha restores p53 activity via Hdm2 and reverses chemoresistance of renal carcinoma cells.
Roberts AM; Watson IR; Evans AJ; Foster DA; Irwin MS; Ohh M
Cancer Res; 2009 Dec; 69(23):9056-64. PubMed ID: 19920202
[TBL] [Abstract][Full Text] [Related]
36. An intact HDM2 RING-finger domain is required for nuclear exclusion of p53.
Boyd SD; Tsai KY; Jacks T
Nat Cell Biol; 2000 Sep; 2(9):563-8. PubMed ID: 10980695
[TBL] [Abstract][Full Text] [Related]
37. Benzodiazepinedione inhibitors of the Hdm2:p53 complex suppress human tumor cell proliferation in vitro and sensitize tumors to doxorubicin in vivo.
Koblish HK; Zhao S; Franks CF; Donatelli RR; Tominovich RM; LaFrance LV; Leonard KA; Gushue JM; Parks DJ; Calvo RR; Milkiewicz KL; Marugán JJ; Raboisson P; Cummings MD; Grasberger BL; Johnson DL; Lu T; Molloy CJ; Maroney AC
Mol Cancer Ther; 2006 Jan; 5(1):160-9. PubMed ID: 16432175
[TBL] [Abstract][Full Text] [Related]
38. Stabilization of p53 in human cytomegalovirus-initiated cells is associated with sequestration of HDM2 and decreased p53 ubiquitination.
Chen Z; Knutson E; Wang S; Martinez LA; Albrecht T
J Biol Chem; 2007 Oct; 282(40):29284-95. PubMed ID: 17698841
[TBL] [Abstract][Full Text] [Related]
39. Inducible COX-2-dependent apoptosis in human ovarian cancer cells.
Lin C; Crawford DR; Lin S; Hwang J; Sebuyira A; Meng R; Westfall JE; Tang HY; Lin S; Yu PY; Davis PJ; Lin HY
Carcinogenesis; 2011 Jan; 32(1):19-26. PubMed ID: 21187340
[TBL] [Abstract][Full Text] [Related]
40. Interferon-inducible protein IFIXalpha1 functions as a negative regulator of HDM2.
Ding Y; Lee JF; Lu H; Lee MH; Yan DH
Mol Cell Biol; 2006 Mar; 26(5):1979-96. PubMed ID: 16479015
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]